Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7801 AL 7815

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease

Salloway S, Wojtowicz J, Voyle N, Lane CA, Klein G, Lyons M, Rossomanno S, Mazzo F, Bullain S, Barkhof F, Bittner T, Schneider A, Grundman M, Aldea R, Boada M, Smith J, Doody R.

JAMA Neurol. 2025 Jan 1;82(1):19-29. doi: 10.1001/jamaneurol.2024.3937.

Traditional Chinese Medicine for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Chen Y, Zhang D, Chen T, Zhao L, Wen L, Hou R.

Am J Chin Med. 2025;53(1):1-15. doi: 10.1142/S0192415X25500016. Epub 2025 Feb 21.

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial

Macfarlane S, Grimmer T, Teo K, O'Brien TJ, Woodward M, Grunfeld J, Mander A, Brodtmann A, Brew BJ, Morris P, Short C, Kurrle S, Lai R, Bharadwaj S, Drysdale P, Sturm J, Lewis SJG, Barton D, Kalafatis C, Sharif S, Perry R, Mannering N, MacSweeney JE, Pearson S, Evans C, Krishna V, Thompson A, Munisamy M, Bhatt N, Asher A, Connell S, Lynch J, Rutgers SM, Dautzenberg PL, Prins N, Oschmann P, Frölich L, Tacik P, Peters O, Wiltfang J, Henri-Bhargava A, Smith E, Pasternak S, Frank A, Chertkow H, Ingram J, Hsiung GR, Brittain R, Tartaglia C, Cohen S, Villa LM, Gordon E, Jubault T, Guizard N, Tucker A, Kaufmann WE, Jin K, Chezem WR, Missling CU, Sabbagh MN.

J Prev Alzheimers Dis. 2025 Jan;12(1):100016. doi: 10.1016/j.tjpad.2024.100016. Epub 2025 Jan 1.

Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities

Cogswell PM, Andrews TJ, Barakos JA, Barkhof F, Bash S, Benayoun MD, Chiang GC, Franceschi AM, Jack CR Jr, Pillai JJ, Poussaint TY, Raji CA, Ramanan VK, Tanabe J, Tanenbaum L, Whitlow CT, Yu FF, Zaharchuk G, Zeinah M, Benzinger TS; ASNR Alzheimer, ARIA, and Dementia Study Group.

AJNR Am J Neuroradiol. 2025 Jan 8;46(1):24-32. doi: 10.3174/ajnr.A8469.

Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy

Zheng Q, Wang X.

Protein Cell. 2025 Feb 1;16(2):83-120. doi: 10.1093/procel/pwae026.

Understanding the correlative relationship between obesity and Alzheimer disease

Foreman RM, Rodriguez M.

Nurse Pract. 2025 Sep 1;50(9):40-45. doi: 10.1097/01.NPR.0000000000000355. Epub 2025 Aug 28.

Epilepsy and Alzheimer disease: New insights and perspectives

Dupont S.

Rev Neurol (Paris). 2025 May;181(5):382-390. doi: 10.1016/j.neurol.2025.03.005. Epub 2025 Mar 31.

Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's disease

Wen B, Han X, Gong J, Wang P, Sun W, Xu C, Shan A, Wang X, Luan H, Li S, Li R, Guo J, Chen R, Li C, Sun Y, Lv S, Wei C.

Alzheimers Dement. 2025 Feb;21(2):e14547. doi: 10.1002/alz.14547. Epub 2025 Jan 27.

Hypertension and Alzheimer's disease: Pathological interplay, comorbidity risks, and new strategies for synergistic management

Wei X, Li L, Zhao G, Luan Y, Wang Q, Ning W.

Clin Exp Hypertens. 2025 Dec 31;47(1):2595154. doi: 10.1080/10641963.2025.2595154. Epub 2025 Dec 5.

Alzheimer's Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective

Scarano N, Musumeci F, Casini B, Brullo C, D'Ursi P, Fossa P, Schenone S, Cichero E.

Int J Mol Sci. 2025 Jul 20;26(14):6980. doi: 10.3390/ijms26146980.

Brexpiprazole: A Balance of Risks and Benefits

Hitt EM.

Sr Care Pharm. 2025 Mar 1;40(3):115-122. doi: 10.4140/TCP.n.2025.115.

Emerging Concepts in Diagnosis, Pathologic Features, and Treatment of Limbic-Predominant Amnestic Neurodegenerative Syndrome (LANS): A Narrative Review

Serio MA, Dethloff DR, Curry GC, Beesley ML, Shekoohi S, Kaye AD.

Adv Ther. 2025 Nov;42(11):5300-5312. doi: 10.1007/s12325-025-03337-x. Epub 2025 Aug 29.

Emerging Pharmacological Approaches for Psychosis and Agitation in Alzheimer's Disease

Imbimbo C, Cotta Ramusino M, Leone S, Mazzacane F, De Franco V, Gatti A, Perini G, Costa A.

CNS Drugs. 2025 Feb;39(2):143-160. doi: 10.1007/s40263-024-01133-9. Epub 2024 Dec 2.

Effect of Alzheimer's disease medications on neurocognitive outcomes in children and adolescents with autism spectrum disorder and low IQ: a scoping review

Diamandis N, van den Anker JN, Denisova K.

Transl Psychiatry. 2025 Nov 17;15(1):475. doi: 10.1038/s41398-025-03655-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias